Talis Net Invested Capital from 2010 to 2024
| TLIS Stock | USD 9.00 0.18 1.96% |
Net Invested Capital | First Reported 2010-12-31 | Previous Quarter 69.1 M | Current Value 45.5 M | Quarterly Volatility 89.9 M |
Check Talis Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Talis Biomedical's main balance sheet or income statement drivers, such as Net Interest Income of 50.4 K, Interest Income of 50.4 K or Depreciation And Amortization of 3.2 M, as well as many indicators such as Price To Sales Ratio of 34.51, Dividend Yield of 0.0 or PTB Ratio of 0.21. Talis financial statements analysis is a perfect complement when working with Talis Biomedical Valuation or Volatility modules.
Talis | Net Invested Capital |
Latest Talis Biomedical's Net Invested Capital Growth Pattern
Below is the plot of the Net Invested Capital of Talis Biomedical Corp over the last few years. It is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. Talis Biomedical's Net Invested Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Talis Biomedical's overall financial position and show how it may be relating to other accounts over time.
| Net Invested Capital | 10 Years Trend |
|
Net Invested Capital |
| Timeline |
Talis Net Invested Capital Regression Statistics
| Arithmetic Mean | (8,161,278) | |
| Coefficient Of Variation | (1,102) | |
| Mean Deviation | 67,727,326 | |
| Median | (52,002,000) | |
| Standard Deviation | 89,930,466 | |
| Sample Variance | 8087.5T | |
| Range | 342.5M | |
| R-Value | 0.59 | |
| Mean Square Error | 5647.2T | |
| R-Squared | 0.35 | |
| Significance | 0.02 | |
| Slope | 11,924,010 | |
| Total Sum of Squares | 113224.8T |
Talis Net Invested Capital History
About Talis Biomedical Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Talis Biomedical income statement, its balance sheet, and the statement of cash flows. Talis Biomedical investors use historical funamental indicators, such as Talis Biomedical's Net Invested Capital, to determine how well the company is positioned to perform in the future. Although Talis Biomedical investors may use each financial statement separately, they are all related. The changes in Talis Biomedical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Talis Biomedical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Talis Biomedical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Talis Biomedical. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Invested Capital | 69.1 M | 45.5 M |
Pair Trading with Talis Biomedical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Talis Biomedical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Talis Biomedical will appreciate offsetting losses from the drop in the long position's value.Moving against Talis Stock
| 0.62 | SCLXW | Scilex Holding | PairCorr |
| 0.55 | ATXI | Avenue Therapeutics | PairCorr |
| 0.44 | CRL | Charles River Labora | PairCorr |
| 0.41 | IQV | IQVIA Holdings Sell-off Trend | PairCorr |
| 0.39 | ANVS | Annovis Bio Earnings Call Today | PairCorr |
The ability to find closely correlated positions to Talis Biomedical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Talis Biomedical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Talis Biomedical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Talis Biomedical Corp to buy it.
The correlation of Talis Biomedical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Talis Biomedical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Talis Biomedical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Talis Biomedical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Talis Stock Analysis
When running Talis Biomedical's price analysis, check to measure Talis Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Talis Biomedical is operating at the current time. Most of Talis Biomedical's value examination focuses on studying past and present price action to predict the probability of Talis Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Talis Biomedical's price. Additionally, you may evaluate how the addition of Talis Biomedical to your portfolios can decrease your overall portfolio volatility.